Immunohistochemistry Market size is predicted to surpass $4.5+ Bn, Globally, by 2031 at 6.5+% CAGR

Allied Market Research published a report, titled, “Immunohistochemistry Market by Product (Antibody, Reagents, Kits, Equipment), by Application (Diagnosis, Research Applications, Forensic), by End User (Hospital and Diagnostic Labs, Research Institutes and Academic Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031.” According to the report, the global immunohistochemistry industry generated $2.4 billion in 2021, and is expected to reach $4.5 billion by 2031, manifesting a CAGR of 6.5% from 2022 to 2031.

Download Sample Report– https://www.alliedmarketresearch.com/request-sample/11564

Impact of Covid-19 on Immunohistochemistry Market-

• The immunohistochemistry market impacted positively during the Covid-19 pandemic, owing to surge in prevalence of Covid-19 infections and surge in the adoption of immunohistochemistry techniques for detecting Covid-19 infections.
• According to a research published in the Laboratory Investigation journal in July 2020, the immunohistochemical (IHC) and in situ hybridization (ISH) assays were utilized for detecting Covid-19 infection.
• The demand for immunohistochemistry techniques surged considerably among research organizations, hospitals, and universities to carry out tests and research activities to gather more information about Covid-19 infection and find out treatment options.

Leading Market Players

Abcam PLC,Agilent Technologies Inc.,Becton, Dickinson & Company,Biocare Medical LLC,Biogenex Laboratories,Bio-Rad Laboratories Inc.,Cell Signaling Technology Inc.,Diagnostic Biosystems Inc.,Eagle Biosciences Inc.,F. Hoffman-La Roche AG,Genemed Biotechnologies Inc.,Merck KGaA,Miltenyi Biotec GmbH,PerkinElmer Inc.,Rockland Immunochemicals Inc.,Takara Bio Inc.,Thermofisher Scientific Inc.

Get detailed COVID-19 impact analysis on the Immunohistochemistry Market- https://www.alliedmarketresearch.com/request-for-customization/11564?reqfor=covid

The COVID-19 outbreak has positively impacted the immunohistochemistry market, owing to the increase in the prevalence of COVID-19 infections across the world and the rise in the adoption of immunohistochemistry techniques for the detection of COVI-19 infections. For instance, according to an article published in Laboratory Investigation journal in July 2020, immunohistochemical (IHC) and in situ hybridization (ISH) assays are used for detection of the SARS-CoV-2. It was found that all samples were stained positive by IHC and ISH whereas all specimens from non-COVID-19 patients were IHC and ISH negative. Thus, the impact of the coronavirus (COVID-19) pandemic has remained positive on the global immunohistochemistry (IHC) market.

Immunohistochemistry Market Report Highlights

Aspects	Details
Product	Antibody Type Primary Antibodies Secondary Antibodies Reagents Type Histological Stains Blocking Sera and Reagents Chromogenic Substrates Diluents Fixation Reagents Organic Solvents Proteolytic Enzymes Other Kits Type IHC Kits for Animal Tissue IHC Kits for Human Tissue Equipment Type Slide staining Systems Tissue Processing Systems Slide Scanners Others
Application	Diagnosis Type Infectious diseases Neurological diseases Nephrological diseases Autoimmune diseases Cancer Others Research Applications Type Drug Testing Others Forensic
End User	Hospital and Diagnostic Labs Research Institutes and Academic Institutes Others
By Region	North America  (U.S., Canada, Mexico) Europe  (UK, Italy, Spain, Rest of Europe, Germany, France) Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest Of Asia Pacific) LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)